Introduction
The endothelium plays a key role in the control of vasomotor tone via the release of diffusible factors such as prostanoids, nitric oxide, and endothelial derived hyperpolarising factor (EDHF). The identity of EDHF is controversial, although there has been considerable support for a role of cytochrome P450 (CYP) metabolites (Archer et al., 2003; Campbell et al., 1996; Fisslthaler et al., 1999) .
However, the specific pharmacological tools required for investigating this theory have only recently been made available Gauthier et al., 2002) .
Epoxyeicosatrienoic acids are CYP metabolites, which induce vasodilatation by activating smooth muscle large conductance Ca 2+ sensitive K + (BK Ca ) (Archer et al, 2003) . The epoxyeicosatrienoic acids are currently thought to be important mediators in EDHF responses. Specifically, acetylcholine induced vasodilatation, in human and bovine tissue, is inhibited by P450 inhibitors and by the epoxyeicosatrienoic acid analogue 14, 15-epoxyeicosa-5 (Z) enoic acid (14, 15 EEZE) (Archer et al, 2003; Gauthier et al, 2002) . 14, 15 EEZE may therefore represent the first EDHF antagonist and consequently is a very useful pharmacological tool in the study of vascular biology. However, a full pharmacological analysis of 14, 15, EEZE has not been made. In the present study we present data which shows that 14, 15 EEZE is a vasodilator in its own right. In fact, 14, 15 EEZE was more potent a vasodilator than the 'agonist' 11-nonyloxyundec-8(Z)-enoic acid . 4
Methods
Male Black 6 C57 mice (28.2 ± 1.24g) were killed by lethal exposure to CO 2 . 
Effects of the agonists 11-nonyloxyundec-8(Z)-enoic acid or the antagonists 14, 15 EEZE on vasodilator effects in pre-contracted vessels
Vessels were precontracted with the EC 80 concentration of U46619 followed by the cumulative addition of either 11-nonyloxyundec-8(Z)-enoic acid or 14, 15 EEZE. In some experiments, vessels were pre-contracted with 10 M) was added in a cumulative fashion after contraction with U46619.
Materials
All drugs were purchased from Sigma Chemical Co. Gillingham, Dorset, UK, except for 11-nonyloxyundec-8(Z)-enoic acid and 14, 15-EEZE, which were a gift generously provided by J. R. Falck (Department of Pharmacology and Toxicology, University of Texas South-western Medical school, Dallas).
Acetylcholine and methoxamine solutions were freshly prepared each day in aqueous solutions. 14, 15-EEZE, 11-nonyloxyundec-8(Z)-enoic acid, U46619 or PGF 2α
were prepared in high concentration 'stock' solutions dissolved in ethanol and were 
Results

Effects of 14, 15 EEZE on vasodilator responses
U46619 induced concentration dependent vasoconstriction of vessels. Pretreatment of vessels with 14, 15 EEZE resulted in concentration dependent inhibition of U46619 induced contractions ( figure 1a) . Similarly, methoxamine induced concentration dependent vasoconstriction of vessels which were also inhibited by 14, 15 EEZE (figure 1b). 14, 15 EEZE appeared more potent an inhibitor of U46619 than methoxamine induced vasoconstriction.
14, 15 EEZE was also able to induce direct and immediate vasodilator responses 
Effect of 11-nonyloxyundec-8(Z)-enoic acid on vasodilator responses
11-nonyloxyundec-8(Z)-enoic acid induced vasodilator responses in U46619
contracted vessels with an approximate EC 50 of approximately 10 -5 M (figure 2b). The dilator effects 11-nonyloxyundec-8(Z)-enoic acid were antagonised by 10 -5 M 14, 15 EEZE (Figure 2b ).
Discussion
11-nonyloxyundec-8(Z)-enoic acid and 14, 15 EEZE are pharmacological tools used to investigate EDHF candidates. In the present study we show that 11-nonyloxyundec-8(Z)-enoic acid is an effective vasodilator of murine mesenteric vessels. We also show that 14, 15 EEZE is an effective antagonist of these responses.
However, we also show that 14, 15 EEZE is a vasodilator with a similar potency to 11-nonyloxyundec-8(Z)-enoic acid .
Vasodilator epoxyeicosatrienoic acids are metabolic products of arachidonic acid breakdown by cytochrome P-450 epoxygenases in the endothelium. However, cytochrome P-450 ω-hydroxylase metabolises arachidonic acid in the smooth muscle cells to form 20-hydroxyeicosatetraenoic acid (20-HETE), which may induce vasoconstriction. Thus, the ratio of arachidonic acid metabolites present in the vessel wall dictates the level of tone of the smooth muscle cells, and any antagonist used to study these enzymes needs to be highly specific. Consequently, Gauthier and coworkers (2002) designed and generated a range of analogues, of which 14, 15 EEZE was found to have important effects. 14, 15 EEZE was found to be a highly specific epoxyeicosatrienoic acid antagonist, with no effect on the action or synthesis of 20-HETE (Gauthier et al., 2000) .
It has been proposed that the endothelium synthesises epoxyeicosatrienoic acids which are released upon stimulation by agonist such as acetylcholine. The released epoxyeicosatrienoic acids open large K Ca channels in smooth muscle cells, and thus induce hyperpolarisation and relaxation of the artery (Campbell et al, 1996) . However, the vascular type may be sensitive to the type of epoxyeicosatrienoic acid released, since rat renal arteries relax in the presence of 11-nonyloxyundec-8(Z)-enoic acid but 14, 15 epoxyeicosatrienoic acid had little effect (Zou et al., 1996) . 
